nocodazole has been researched along with Ovarian Neoplasms in 5 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santibáñez, M | 1 |
| Gallardo, D | 1 |
| Morales, F | 1 |
| López, A | 1 |
| Prada, D | 1 |
| Mendoza, J | 1 |
| Castro, C | 1 |
| de León, DC | 1 |
| Oñate, LF | 1 |
| Perez, D | 1 |
| Mohar, A | 1 |
| Herrera, LA | 1 |
| Wang, Q | 1 |
| Moyret-Lalle, C | 1 |
| Couzon, F | 1 |
| Surbiguet-Clippe, C | 1 |
| Saurin, JC | 1 |
| Lorca, T | 1 |
| Navarro, C | 1 |
| Puisieux, A | 1 |
| McKay, TR | 1 |
| Bell, S | 1 |
| Tenev, T | 1 |
| Stoll, V | 1 |
| Lopes, R | 1 |
| Lemoine, NR | 1 |
| McNeish, IA | 1 |
| Lee, EA | 1 |
| Keutmann, MK | 1 |
| Dowling, ML | 1 |
| Harris, E | 1 |
| Chan, G | 1 |
| Kao, GD | 1 |
| Ding, M | 1 |
| Robinson, JM | 1 |
| Behrens, BC | 1 |
| Vandré, DD | 1 |
5 other studies available for nocodazole and Ovarian Neoplasms
| Article | Year |
|---|---|
The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer.
Topics: Biomarkers, Pharmacological; Calcium-Binding Proteins; Carcinoma, Ovarian Epithelial; Cell Cycle Pro | 2013 |
Alterations of anaphase-promoting complex genes in human colon cancer cells.
Topics: Anaphase-Promoting Complex-Cyclosome; Antineoplastic Agents; Apc3 Subunit, Anaphase-Promoting Comple | 2003 |
Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
Topics: Adenoviridae; Animals; Apoptosis; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Cycle; Drug Screen | 2003 |
Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; CDC2 Protein Kinase; Cell Cycle Proteins; Cell | 2004 |
The microtubule cytoskeleton in human phagocytic leukocytes is a highly dynamic structure.
Topics: Drug-Related Side Effects and Adverse Reactions; Eosinophils; Female; Fluorescent Antibody Technique | 1995 |